82 related articles for article (PubMed ID: 25596996)
1. PTEN expression in colorectal adenomas: relationship to morphology and cell heterogeneity.
Bendib M; Badescu A; Handra-Luca A
Pathol Res Pract; 2015 Mar; 211(3):248-51. PubMed ID: 25596996
[TBL] [Abstract][Full Text] [Related]
2. P38 expression in colorectal adenomas: relationships to cell proliferation, stem phenotype and AKT pathway proteins.
Handra-Luca A; Bendib M; Magkou C
Minerva Gastroenterol Dietol; 2020 Sep; 66(3):208-210. PubMed ID: 32218423
[TBL] [Abstract][Full Text] [Related]
3. Identification of CD133+ cells in pituitary adenomas.
Yunoue S; Arita K; Kawano H; Uchida H; Tokimura H; Hirano H
Neuroendocrinology; 2011; 94(4):302-12. PubMed ID: 21912092
[TBL] [Abstract][Full Text] [Related]
4. Nuclear Expression of CD133 Is Associated with Good Prognosis in Patients with Colorectal Adenocarcinoma.
Lee YM; Yeo MK; Seong IO; Kim KH
Anticancer Res; 2018 Aug; 38(8):4819-4826. PubMed ID: 30061254
[TBL] [Abstract][Full Text] [Related]
5. PTEN status is related to cell proliferation and self-renewal independent of CD133 phenotype in the glioma-initiating cells.
Cheng RB; Ma RJ; Wang ZK; Yang SJ; Lin XZ; Rong H; Ma Y
Mol Cell Biochem; 2011 Mar; 349(1-2):149-57. PubMed ID: 21110069
[TBL] [Abstract][Full Text] [Related]
6. PTEN loss and KRAS activation leads to the formation of serrated adenomas and metastatic carcinoma in the mouse intestine.
Davies EJ; Marsh Durban V; Meniel V; Williams GT; Clarke AR
J Pathol; 2014 May; 233(1):27-38. PubMed ID: 24293351
[TBL] [Abstract][Full Text] [Related]
7. Colon cancer stem cell markers CD44 and CD133 in patients with colorectal cancer and synchronous hepatic metastases.
Jing F; Kim HJ; Kim CH; Kim YJ; Lee JH; Kim HR
Int J Oncol; 2015 Apr; 46(4):1582-8. PubMed ID: 25625240
[TBL] [Abstract][Full Text] [Related]
8. The stem cell marker CD133 is highly expressed in sessile serrated adenoma and its borderline variant compared with hyperplastic polyp.
Mohammadi M; Bzorek M; Bonde JH; Nielsen HJ; Holck S
J Clin Pathol; 2013 May; 66(5):403-8. PubMed ID: 23436931
[TBL] [Abstract][Full Text] [Related]
9. The relationship between and clinical significance of MicroRNA-32 and phosphatase and tensin homologue expression in colorectal cancer.
Wu W; Yang P; Feng X; Wang H; Qiu Y; Tian T; He Y; Yu C; Yang J; Ye S; Zhou Y
Genes Chromosomes Cancer; 2013 Dec; 52(12):1133-40. PubMed ID: 24123284
[TBL] [Abstract][Full Text] [Related]
10. An immunohistochemical study of Ki-67 in colorectal adenoma.
Radovanovic-Dinic B; Nagorni A; Katic V; Stamenkovic I; Zlatic A
Med Arh; 2009; 63(1):16-8. PubMed ID: 19419120
[TBL] [Abstract][Full Text] [Related]
11. CD133 marks for colorectal adenocarcinoma.
Chew MF; Teoh KH; Cheah PL
Malays J Pathol; 2012 Jun; 34(1):25-8. PubMed ID: 22870594
[TBL] [Abstract][Full Text] [Related]
12. Effect of EpCAM, CD44, CD133 and CD166 expression on patient survival in tumours of the ampulla of Vater.
Piscuoglio S; Lehmann FS; Zlobec I; Tornillo L; Dietmaier W; Hartmann A; Wünsch PH; Sessa F; Rümmele P; Baumhoer D; Terracciano LM
J Clin Pathol; 2012 Feb; 65(2):140-5. PubMed ID: 22130902
[TBL] [Abstract][Full Text] [Related]
13. [Expression of survivin in colorectal adenoma and adenocarcinoma].
Guan J; Chen J; Luo YF; Cao JL; Zhao H; Hao J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Jun; 29(3):398-401. PubMed ID: 17633470
[TBL] [Abstract][Full Text] [Related]
14. [Expression characteristics of PTEN and NDRG1 in colorectal carcinoma and their prognostic value].
Zhang GX; Qian ZY; Yang LJ; Wang F; Shen H
Zhonghua Bing Li Xue Za Zhi; 2017 Apr; 46(4):240-244. PubMed ID: 28376589
[No Abstract] [Full Text] [Related]
15. Correlation of aberrant expression of CD133 with FHIT and malignant phenotype of colorectal adenocarcinoma.
Li H; Zhao P; Lu Y; Lu Y
Int J Colorectal Dis; 2012 Aug; 27(8):1015-20. PubMed ID: 22315171
[TBL] [Abstract][Full Text] [Related]
16. [Expression and significance of Bmi-1 and Ki67 in colorectal carcinoma tissues].
Lin MX; Wen ZF; Feng ZY; He D
Ai Zheng; 2008 Dec; 27(12):1321-6. PubMed ID: 19080002
[TBL] [Abstract][Full Text] [Related]
17. Transcriptome analysis of CD133-positive stem cells and prognostic value of survivin in colorectal cancer.
Kim ST; Sohn I; DO IG; Jang J; Kim SH; Jung IH; Park JO; Park YS; Talasaz A; Lee J; Kim HC
Cancer Genomics Proteomics; 2014; 11(5):259-66. PubMed ID: 25331798
[TBL] [Abstract][Full Text] [Related]
18. Expression of the stem cell marker CD133 is related to tumor development in colorectal carcinogenesis.
Kazama S; Kishikawa J; Kiyomatsu T; Kawai K; Nozawa H; Ishihara S; Watanabe T
Asian J Surg; 2018 May; 41(3):274-278. PubMed ID: 28190751
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinoma.
Xi HQ; Zhao P
J Clin Pathol; 2011 Jun; 64(6):498-503. PubMed ID: 21415057
[TBL] [Abstract][Full Text] [Related]
20. Correlation of epidermal growth factor receptor with morphological features of colorectal advanced adenomas: a pilot correlative case series.
Bansal A; Liu X; McGregor DH; Singh V; Hall S
Am J Med Sci; 2010 Oct; 340(4):296-300. PubMed ID: 20622650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
